365.6K NSE+BSE Volume
NSE 25 Apr, 2025 3:31 PM (IST)
Ex-date | Purpose | Notes |
---|---|---|
11 Feb 2025 | Quarterly Results | - |
13 Nov 2024 | Quarterly Results | - |
08 Aug 2024 | Quarterly Results | - |
16 May 2024 | Audited Results & Final Dividend | - |
07 Feb 2024 | Quarterly Results | - |
07 Nov 2023 | Quarterly Results | - |
10 Aug 2023 | Quarterly Results | - |
25 May 2023 | Audited Results & Dividend | - |
10 Feb 2023 | Quarterly Results | - |
11 Nov 2022 | Quarterly Results | - |
10 Aug 2022 | Quarterly Results | - |
27 May 2022 | Audited Results & Final Dividend | - |
03 Feb 2022 | Quarterly Results | - |
27 Oct 2021 | Quarterly Results | - |
06 Aug 2021 | Quarterly Results | - |
27 May 2021 | Audited Results & Final Dividend | - |
22 Jan 2021 | Quarterly Results | - |
28 Oct 2020 | Quarterly Results & Interim Dividend | - |
11 Aug 2020 | Quarterly Results | - |
30 Jun 2020 | Audited Results | - |
01 Feb 2020 | Quarterly Results | - |
31 Jan 2020 | Quarterly Results | - |
24 Oct 2019 | Quarterly Results | - |
08 Aug 2019 | Quarterly Results | - |
08 May 2019 | Audited Results | - |
21 Jan 2019 | Quarterly Results | - |
05 Nov 2018 | Quarterly Results | - |
08 Aug 2018 | Quarterly Results | - |
29 May 2018 | Audited Results | - |
13 Feb 2018 | Quarterly Results | - |
14 Dec 2017 | Quarterly Results | - |
13 Sep 2017 | Quarterly Results | - |
24 May 2017 | Audited Results | - |
07 Feb 2017 | Quarterly Results | - |
14 Nov 2016 | Quarterly Results | 1. Re-appointment of Mr. Surendra Somani, Executive Vice Chairman 2. Mr. Surendra Somani,Executive Vice Chairman, Mr. Ajit Jain, Chief Operating Officer and Mr. Sunil Sodhani, Company Secretary. |
09 Aug 2016 | Quarterly Results | - |
30 May 2016 | Audited Results | - |
11 Feb 2016 | Quarterly Results | - |
06 Nov 2015 | Quarterly Results | - |
12 Aug 2015 | Quarterly Results | - |
14 Jul 2015 | Others | Sale of Consumer Care Division of the Company. |
28 May 2015 | Audited Results | - |
13 Feb 2015 | Quarterly Results | - |
12 Nov 2014 | Quarterly Results | - |
29 Sep 2014 | Others | (1) To consider issue of Equity Shares and/ or Warrants on Preferential basis to Promoter Group. (2) To consider Slump Sales of (API) business to its Subsidiary Co. Kopran Research Laboratories Ltd. |
14 Aug 2014 | Quarterly Results | - |
28 May 2014 | Audited Results | - |
13 Feb 2014 | Quarterly Results | - |
13 Nov 2013 | Quarterly Results | - |
10 Aug 2013 | Quarterly Results | - |
29 May 2013 | Audited Results | - |
12 Feb 2013 | Quarterly Results | - |
10 Nov 2012 | Quarterly Results | - |
14 Aug 2012 | Quarterly Results | - |
13 Jul 2012 | Audited Results | (Revised) |
15 May 2012 | Quarterly Results | - |
11 Feb 2012 | Quarterly Results | - |
12 Nov 2011 | Quarterly Results | - |
29 Jul 2011 | Audited & Quarterly Results | - |
14 May 2011 | Quarterly Results | - |
11 Feb 2011 | Quarterly Results | - |
15 Nov 2010 | Quarterly Results | - |
10 Aug 2010 | Audited, Quarterly Results & Others | The Board has allotted 19,50,000 Equity Shares of Rs. 10/- each for cash at par, (i.e. at a price determined as per SEBI Guidelines) against 19,50,000 CW's held by Panorama Finvest Pvt. Ltd. |
14 May 2010 | Quarterly Results | - |
29 Jan 2010 | Quarterly Results | - |
31 Oct 2009 | Quarterly Results | - |
29 Jul 2009 | Quarterly Results | - |
30 Jun 2009 | Audited Results & Others | To issue on Preferential basis 19,50,000 Warrants and 18,50,000 equity shares of Rs 10 each, to the Promoters / Associates at a price arrived at as per SEBI Guidelines. |
30 Jan 2009 | Quarterly Results | - |
25 Oct 2008 | Quarterly Results | - |
11 Oct 2008 | Others | To divest its stake in the Joint Ventures namely, Globalpharma LLC, Dubai and Kampala Pharmaceutical Industries, Uganda. |
30 Jul 2008 | Quarterly Results | - |
30 Jun 2008 | Audited Results | - |
31 Jan 2008 | Quarterly Results | (Revised) |
08 Jan 2008 | Audited Results | - |
03 Jan 2008 | Audited Results (18 months) | - |
21 Sep 2007 | Quarterly Results | - |
30 Jun 2007 | Audited Results | - |
30 Apr 2007 | Quarterly Results | - |
31 Jan 2007 | Quarterly Results | - |
30 Oct 2006 | Quarterly Results | - |
24 Aug 2006 | Preferential Allotment of shares | To consider Preferential Allotment of Equity Shares pursuant to Section 81(1A) of the Companies Act, 1956 to Banks and Financial Institutions. |
31 Jul 2006 | Accounts & Quarterly Results | - |
27 Apr 2006 | Quarterly Results | - |
21 Apr 2006 | Allotment of equity shares & Warrants | a. 47,20,000 Equity Shares of Rs 10/- each, at a price of Rs 54.70/- per Equity Share b. 58,42,000 Warrants with an option to subscribe into equal number of Equity Shares. |
11 Mar 2006 | Further issue of Equity Shares | Inter alia, to consider, a proposal of further issue of Equity Shares in one or more trenches, by way of private placement / preferential allotment. |
31 Jan 2006 | Quarterly Results | - |
24 Oct 2005 | Quarterly Results | - |
03 Jun 2005 | Issue and allotment of Warrants | Issue and allotment of 12150000 warrants to Clear Water Capital Partner(Cyprus) Ltd. |
25 Apr 2005 | Unaudited Financial Results | - |
11 Mar 2005 | Issue of equity shares | To consider a proposal to further issue of equity in one or more trenches, by way of private placement / preferential allotment of equity shares. |
29 Jan 2005 | Quarterly Results & Others | to finalize the effective date and to consider & approve allotment of Eq. Shares by the Co. to the shareholders of Kopran Pharmaceuticals in view of Order passed by the Hon'ble High Court of Bombay. |
29 Oct 2004 | Quarterly Results | - |
31 Jul 2004 | Quarterly Results & Accounts | - |
29 Apr 2004 | Quarterly Results | - |
30 Jan 2004 | Quarterly Results | - |
31 Oct 2003 | Quarterly Results | - |
25 Sep 2003 | Accounts | - |
31 Jul 2003 | Quarterly Results | (Revised) |
29 Apr 2003 | Quarterly Results | - |